header logo image header logo text
Downloads Login
General Information
ZFIN ID: ZDB-PUB-160713-2
Quantitative proteomics analysis of zebrafish exposed to sub-lethal dosages of β-methyl-amino-L-alanine (BMAA)
Frøyset, A.K., Khan, E.A., Fladmark, K.E.
Date: 2016
Source: Scientific Reports 6: 29631 (Journal)
Registered Authors:
Keywords: Molecular neuroscience, Neurodegenerative diseases
MeSH Terms:
  • Amino Acids, Diamino/administration & dosage*
  • Animals
  • Fish Proteins/metabolism*
  • Glycogen Synthase Kinase 3/metabolism
  • Glycogen Synthase Kinase 3 beta/metabolism
  • Heart Rate
  • Proteomics
  • Zebrafish/metabolism*
PubMed: 27404450 Full text @ Sci. Rep.
The non-protein amino acid β-methylamino-L-alanine (BMAA) is a neurotoxin present in microalgae and shown to accumulate in the food web. BMAA has been linked to the complex neurodegenerative disorder of Guam and to increased incidents sporadic ALS. Two main neurotoxic routes are suggested; an excitotoxic by acting as an agonist towards glutamate receptors and a metabolic by misincorporating into cellular proteins. We have used zebrafish, an increasingly used model for neurodegenerative diseases, to further identify signaling components involved in BMAA-induced toxicity. Zebrafish embryos were exposed to sub-lethal dosages of BMAA and a label-free proteomics analysis was conducted on larvae 4 days post fertilization. The exposed larvae showed no developmental abnormalities, but a reduced heart rate and increased expression of GSK3 isoforms. Search towards a reviewed database containing 2968 entries identified 480 proteins. Only 17 of these were regulated 2-fold or more in the exposed larvae. Seven of these proteins could be associated to glutamate receptor signaling and recycling. The remaining nine have all been linked to disturbance in protein homeostasis, reactive oxygen species (ROS) development or neuronal cell death. We also found that BMAA influenced the endocannabinoid system by up-regulation of fatty acid amide hydrolase (FAAH) and that FAAH inhibitor URB597 reduced the BMAA effect on heart rate and GSK3 expression.